Demands for Protection against SARS-CoV-2 in Prisons

被引：1

作者：

Keppler, Karlheinz ^{[1
]}

Stoever, Heino ^{[1
]}

机构：

[1] Frankfurt Univ Appl Sci, Inst Suchtforsch Frankfurt Main ISFF, Frankfurt, Germany

来源：

SUCHT-ZEITSCHRIFT FUR WISSENSCHAFT UND PRAXIS | 2020年 / 66卷 / 04期

关键词：

Prison; SARS-CoV-2; COVID-19; drug dependence; prevention; opioid substitution treatment;

D O I：

10.1024/0939-5911/a000673

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Background: The World Health Organization, Regional Office for Europe has published interim guidance material on how to deal with the coronavirus disease (COVID-19) in prisons and other places of detention. Aim: The measures recommended in the guidance will be complemented by additional demands, especially for drug dependent prisoners.

引用

页码：207 / 211

页数：5

共 50 条

[21] BCG vaccination provides protection against IAV but not SARS-CoV-2
Kaufmann, Eva
Khan, Nargis
Tran, Kim A.
Ulndreaj, Antigona
Pernet, Erwan
Fontes, Ghislaine
Lupien, Andreanne
Desmeules, Patrice
McIntosh, Fiona
Abow, Amina
Moorlag, Simone J. C. F. M.
Debisarun, Priya
Mossman, Karen
Banerjee, Arinjay
Karo-Atar, Danielle
Sadeghi, Mina
Mubareka, Samira
Vinh, Donald C.
King, Irah L.
Robbins, Clinton S.
Behr, Marcel A.
Netea, Mihai G.
Joubert, Philippe
Divangahi, Maziar
CELL REPORTS, 2022, 38 (10):
[22] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
Yuehong Hu
Qiu Sun
Signal Transduction and Targeted Therapy, 7
[23] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Feng, Shuo
Phillips, Daniel J.
White, Thomas
Sayal, Homesh
Aley, Parvinder K.
Bibi, Sagida
Dold, Christina
Fuskova, Michelle
Gilbert, Sarah C.
Hirsch, Ian
Humphries, Holly E.
Jepson, Brett
Kelly, Elizabeth J.
Plested, Emma
Shoemaker, Kathryn
Thomas, Kelly M.
Vekemans, Johan
Villafana, Tonya L.
Lambe, Teresa
Pollard, Andrew J.
Voysey, Merryn
NATURE MEDICINE, 2021, 27 (11) : 2032 - +
[24] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
Hu, Yuehong
Sun, Qiu
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[25] Dissecting antibody-mediated protection against SARS-CoV-2
Zohar, Tomer
Alter, Galit
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (07) : 392 - 394
[26] Managing waning vaccine protection against SARS-CoV-2 variants
Leung, Kathy
Wu, Joseph T.
LANCET, 2022, 399 (10319): : 2 - 3
[27] Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
Chemaitelly, Hiam
Ayoub, Houssein H.
Tang, Patrick
Hasan, Mohammad R.
Coyle, Peter
Yassine, Hadi M.
Al-Khatib, Hebah A.
Smatti, Maria K.
Al-Kanaani, Zaina
Al-Kuwari, Einas
Jeremijenko, Andrew
Kaleeckal, Anvar H.
Latif, Ali N.
Shaik, Riyazuddin M.
Abdul-Rahim, Hanan F.
Nasrallah, Gheyath K.
Al-Kuwari, Mohamed G.
Butt, Adeel A.
Al-Romaihi, Hamad E.
Al-Thani, Mohamed H.
Al-Khal, Abdullatif
Bertollini, Roberto
Abu-Raddad, Laith J.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (18): : 1716 - 1718
[28] MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
Meseda, Clement A.
Stauft, Charles B.
Selvaraj, Prabhuanand
Lien, Christopher Z.
Pedro, Cyntia
Nunez, Ivette A.
Woerner, Amy M.
Wang, Tony T.
Weir, Jerry P.
NPJ VACCINES, 2021, 6 (01)
[29] MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
Clement A. Meseda
Charles B. Stauft
Prabhuanand Selvaraj
Christopher Z. Lien
Cyntia Pedro
Ivette A. Nuñez
Amy M. Woerner
Tony T. Wang
Jerry P. Weir
npj Vaccines, 6
[30] Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching-Lin Hsieh
Sarah R. Leist
Emily Happy Miller
Ling Zhou
John M. Powers
Alexandra L. Tse
Albert Wang
Ande West
Mark R. Zweigart
Jonathan C. Schisler
Rohit K. Jangra
Kartik Chandran
Ralph S. Baric
Jason S. McLellan
Nature Communications, 15

← 1 2 3 4 5 →